Low-risk DCIS. What is it? Observe or excise?

Pinder, S.E., Thompson, A.M. & Wesserling, J. Low-risk DCIS. What is it? Observe or excise?. Virchows Arch 480, 21–32 (2022). https://doi.org/10.1007/s00428-021-03173-8 Abstract The issue of overdiagnosis and overtreatment of lesions detected by breast screening mammography has been debated in both international media and the scientific literature. A proportion of cancers detected by breast screening would never haveSigueSigue leyendo «Low-risk DCIS. What is it? Observe or excise?»

Breast carcinomas of low malignant potential.

Schnitt, S.J., Fend, F. & Decker, T. Breast carcinomas of low malignant potential. Virchows Arch 480, 5–19 (2022). https://doi.org/10.1007/s00428-021-03163-w Abstract Some breast carcinomas have a very low likelihood of metastasis to regional lymph nodes and distant sites and may be considered carcinomas of low malignant potential. In this article, we review the clinical, pathologic, immunophenotypic, and molecularSigueSigue leyendo «Breast carcinomas of low malignant potential.»

Multidisciplinary Masterclass on Breast Cancer.

– Programa – 9 de julio de 2021. 14:45. Bienvenida. Dr Gérard Friedlander – University of Paris Foundation, France. 15:00. Imaging work-up of breast masses. Dr. Marc Abehsera – American Hospital of Paris, Neuilly sur Seine, France.15:30. 2019 WHO updates on breast tumor classification. Dr Paula Ginter – Weill Cornell Medicine, New York, USA.16:00. TrickySigueSigue leyendo «Multidisciplinary Masterclass on Breast Cancer.»